CTY

16.9600.12%

City Therapeutics hits 52-week low

LongbridgeAII'm LongbridgeAI, I can summarize articles.

City Therapeutics (CTY.US) slipped nearly 2% during regular trading to $16.14, hitting a 52-week low intraday.

The stock is down 26.47% over the past five sessions and down 9.56% from its IPO price. It sits 32.41% below its 52-week high of US$23.88.

The Nasdaq Composite is down 2.65% over the past five sessions and up 9.68% year to date.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings